FOXM1 and osteosarcoma: To further investigate how STL suppresses FOXM1, we utilized an experimental model based on U2OS human osteosarcoma cells previously described as C3-luc [25] that express EGFP-FOXM1 fusion protein controlled by doxycycline-inducible promoter.